Literature DB >> 24384817

MYC and transcription elongation.

Peter B Rahl1, Richard A Young.   

Abstract

Most transcription factors specify the subset of genes that will be actively transcribed in the cell by stimulating transcription initiation at these genes, but MYC has a fundamentally different role. MYC binds E-box sites in the promoters of active genes and stimulates recruitment of the elongation factor P-TEFb and thus transcription elongation. Consequently, rather than specifying the set of genes that will be transcribed in any particular cell, MYC's predominant role is to increase the production of transcripts from active genes. This increase in the transcriptional output of the cell's existing gene expression program, called transcriptional amplification, has a profound effect on proliferation and other behaviors of a broad range of cells. Transcriptional amplification may reduce rate-limiting constraints for tumor cell proliferation and explain MYC's broad oncogenic activity among diverse tissues.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24384817      PMCID: PMC3869279          DOI: 10.1101/cshperspect.a020990

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  115 in total

Review 1.  The Oscar-worthy role of Myc in apoptosis.

Authors:  Natalie Meyer; Sam S Kim; Linda Z Penn
Journal:  Semin Cancer Biol       Date:  2006-07-14       Impact factor: 15.707

2.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

3.  Myc Regulation of mRNA Cap Methylation.

Authors:  Victoria H Cowling; Michael D Cole
Journal:  Genes Cancer       Date:  2010-06

Review 4.  The Warburg effect in 2012.

Authors:  Jean-Pierre Bayley; Peter Devilee
Journal:  Curr Opin Oncol       Date:  2012-01       Impact factor: 3.645

5.  Evidence for an alternative glycolytic pathway in rapidly proliferating cells.

Authors:  Matthew G Vander Heiden; Jason W Locasale; Kenneth D Swanson; Hadar Sharfi; Greg J Heffron; Daniel Amador-Noguez; Heather R Christofk; Gerhard Wagner; Joshua D Rabinowitz; John M Asara; Lewis C Cantley
Journal:  Science       Date:  2010-09-17       Impact factor: 47.728

Review 6.  The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation.

Authors:  Sohail Malik; Robert G Roeder
Journal:  Nat Rev Genet       Date:  2010-10-13       Impact factor: 53.242

Review 7.  Apoptotic signaling by c-MYC.

Authors:  B Hoffman; D A Liebermann
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

8.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 9.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.

Authors:  Chi V Dang
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

Review 10.  Energy regulation: HIF MXIes it up with the C-MYC powerhouse.

Authors:  Patrick D Sutphin; Amato J Giaccia; Denise A Chan
Journal:  Dev Cell       Date:  2007-06       Impact factor: 12.270

View more
  49 in total

Review 1.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 2.  MYC and the control of apoptosis.

Authors:  Steven B McMahon
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

Review 3.  Advances in targeting 'undruggable' transcription factors with small molecules.

Authors:  Matthew J Henley; Angela N Koehler
Journal:  Nat Rev Drug Discov       Date:  2021-05-18       Impact factor: 84.694

Review 4.  Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis-A connection to licensing nodes.

Authors:  Christian Schneeweis; Matthias Wirth; Dieter Saur; Maximilian Reichert; Günter Schneider
Journal:  Small GTPases       Date:  2017-01-20

5.  Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc-mediated microRNA-141 transcription.

Authors:  Mengna Li; Yukun Liu; Yanmei Wei; Chunchun Wu; Hanbing Meng; Weihong Niu; Yao Zhou; Heran Wang; Qiuyuan Wen; Songqing Fan; Zheng Li; Xiayu Li; Jianda Zhou; Ke Cao; Wei Xiong; Zhaoyang Zeng; Xiaoling Li; Yuanzheng Qiu; Guiyuan Li; Ming Zhou
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

Review 6.  Genome recognition by MYC.

Authors:  Arianna Sabò; Bruno Amati
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

Review 7.  Therapeutic strategies to inhibit MYC.

Authors:  Michael R McKeown; James E Bradner
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

Review 8.  MYC cofactors: molecular switches controlling diverse biological outcomes.

Authors:  Stephen R Hann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

9.  Transforming Growth Factor β-Induced Proliferative Arrest Mediated by TRIM26-Dependent TAF7 Degradation and Its Antagonism by MYC.

Authors:  Tadashi Nakagawa; Masaki Hosogane; Makiko Nakagawa; Akane Morohoshi; Ryo Funayama; Keiko Nakayama
Journal:  Mol Cell Biol       Date:  2018-02-12       Impact factor: 4.272

10.  Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.

Authors:  Jonas Ecker; Venu Thatikonda; Gianluca Sigismondo; Florian Selt; Gintvile Valinciute; Ina Oehme; Carina Müller; Juliane L Buhl; Johannes Ridinger; Diren Usta; Nan Qin; Cornelis M van Tilburg; Christel Herold-Mende; Marc Remke; Felix Sahm; Frank Westermann; Marcel Kool; Robert J Wechsler-Reya; Lukas Chavez; Jeroen Krijgsveld; Natalie Jäger; Stefan M Pfister; Olaf Witt; Till Milde
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.